Clinical Trials Directory

Trials / Completed

CompletedNCT01889537

Low Dose Ketamine VR Analgesia During Burn Care Procedure

Low Dose Ketamine to Enhance VR Analgesia During Painful Burn Care Procedure.

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
3 (actual)
Sponsor
National Institute of General Medical Sciences (NIGMS) · NIH
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of the research is to see whether a low dose of ketamine, a medication used to reduce pain, enhances the effectiveness of a virtual reality video game, which is used as a form of distraction from pain during a painful burn care procedure.

Detailed description

This study is conducted in a hospital setting. It is a randomized controlled trial comparing the use of virtual reality distraction (VRD) and standard pain medications to the use of VRD, standard pain medications and a single low dose of ketamine as a means to reduce pain during a painful procedure in patients in the hospital.

Conditions

Interventions

TypeNameDescription
BEHAVIORALVirtual RealityThe patient will receive virtual reality during a burn care procedure

Timeline

Start date
2012-07-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2013-06-28
Last updated
2017-09-01

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01889537. Inclusion in this directory is not an endorsement.